KBKathleen E. Bainbridge

Kathleen E. Bainbridge

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Kathleen E. Bainbridge has a total of 20 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Self-Reported Type 2 Diabetes and the Rate of Hearing Decline in Aging

    by Lauren K. Dillard, Kathleen E. Bainbridge, Lois J. Matthews, Judy R. Dubno

    Purpose: This purpose of this study was to determine the association of Type 2 diabetes with rate of hearing change per year. Method: Participants were from the Medical University of South Carolina Longitudinal Cohort Study of Age-related Hearing Loss. History of Type 2 diabetes was self-reported. Outcome measures were individual audiometric thresholds (0.25–8.0 kHz) and pure-tone average (PTA) of thresholds at frequencies 0.5–4.0 kHz, averaged bilaterally. We used linear mixed regression models to determine the association of diabetes with the rate of annual threshold change at each frequency and PTA, separately. Results are presented as regression coefficients with corresponding 95% confidence intervals (CIs). Results: This study included 1,333 participants with a mean age of 63.5 ( SD = 14.5) years and a mean of 4.7 ( SD = 5.5) years of follow-up; 57.7% were female, and 18.1% were of a racial Minority. The prevalence of Type 2 diabetes was 10.4%. Most (85.3%) participants with diabetes reported the use of diabetes medication(s). Participants with and without diabetes showed similar hearing thresholds at the baseline examination, with mean PTAs of 24.5 (95% CI [23.7, 25.2]) dB HL for participants without diabetes and 24.8 (95% CI [22.6, 26.9]) dB HL for participants with diabetes. Moreover, participants with and without diabetes showed similar rates of annual hearing change in models adjusted for age, sex, and race; PTA change was 0.90 (95% CI [0.86, 0.94]) dB for participants without diabetes and 0.87 (95% CI [0.73, 1.02]) dB for participants with diabetes. Conclusions: Diabetes was not consistently associated with baseline hearing thresholds or rate of change. Additional longitudinal studies are needed to clarify relationships of diabetes and hearing over time. Supplemental Material: https://doi.org/10.23641/asha.30826049


  • Open Access

    Low flavonoid intake is associated with bilateral hearing impairment in US older adults

    by Galya Bigman, Xiaoran Liu, Kathleen E. Bainbridge

    This study investigated the association between dietary flavonoid intake and hearing impairment in older adults aged ≥ 70 years, using cross-sectional data from the National Health and Nutrition Examination Survey 2009–2010 and 2017–2018. Flavonoid intake was estimated from two 24-h dietary recalls and categorised as low or high based on the median intake (85·4 mg/d). Hearing impairment was defined using a pure-tone average > 25 dB in one or both ears. Among the 1492 participants, 55·7 % had bilateral hearing impairment, 15·6 % had unilateral hearing impairment and 28·7 % had normal hearing. These categories were mutually exclusive, based on the presence of hearing impairment in one or both ears. After adjusting for sociodemographic, behavioural and dietary covariates, low flavonoid intake was associated with a 45 % greater odds of bilateral hearing impairment (adjusted OR = 1·45; 95 % CI 1·03, 2·04; P = 0·034), but not associated with unilateral impairment. Marginal associations were also observed for specific flavonoid subclasses, including flavan-3-ols and catechins. A significant interaction with age was observed, whereas no significant interactions were detected with race or sex. These findings suggest that low flavonoid intake may be a modifiable dietary factor associated with age-related bilateral hearing loss. Increasing dietary flavonoid consumption may be associated with benefits for sensory health and could play a modest role in reducing the risk of hearing impairment in older adults, though further research is needed to confirm these findings.


  • Prescription Medication Use and Phantom Odor Perception Among US Adults

    by Kathleen E. Bainbridge, Danita Byrd-Clark

    Prescription medication use may be associated with phantom odor perception. We evaluated associations between number of prescription medications and their therapeutic class and phantom odor perception among US adults.


  • Phantom odor perception and vascular conditions among adults in the United States: National Health and Nutrition Examination Survey 2011–2014

    by Kathleen E. Bainbridge, Danita Byrd‐Clark

    Objectives/Hypothesis: Phantom odor perception has been correlated with burden of vascular risk among older adults. We evaluated associations between vascular conditions and phantom odor perception among adults in the United States.Study Design: Cross‐sectional analysis.Methods: Cross‐sectional data were collected as part of the 2011 to 2014 National Health and Nutrition Examination Survey, yielding a nationally representative sample of 7,417 adults aged 40 years and older. Phantom odor perception was defined as report of an unpleasant, bad, or burning odor when nothing is there. Participants reported on vascular conditions including history of stroke. Total cholesterol and glycated hemoglobinwere measured. High blood pressure was ascertained during an examination.Results: Stroke was associated with a 76% greater likelihood of phantom odor perception. Congestive heart failure and angina were associated with three times and 2.8 times the odds of phantom odor perception among adults 40 to 59 years and 60 years and older, respectively. Adults with diagnosed, but controlled, high cholesterol reported phantom odors more frequently than those without high cholesterol. Adults with diagnosed, but controlled, high blood pressure reported phantom odors more frequently than those without high blood pressure. We observed a threefold greater odds of phantom odor perception among adults aged 60 years and older with diabetes, but only among those who use both insulin and oral medications.Conclusions: Stroke, angina, congestive heart failure, well‐managed high blood pressure, and well‐managed high cholesterol are associated with phantom odor perception. Vascular or metabolic conditions or their treatments may contribute to reporting of phantom odor perception.Level of Evidence: NA Laryngoscope, 130:332–337, 2020


  • Open Access

    Factors Associated With Phantom Odor Perception Among US Adults

    by Kathleen E. Bainbridge, Danita Byrd-Clark, Donald Leopold

    The perception of phantom odors is a qualitative olfactory dysfunction whereby affected individuals perceive odors in the absence of an external stimulus. The sensation is typically unpleasant and described with terms such as “foul,” “rotten,” or “chemical.” There are few epidemiological studies of phantom odor perception. Prevalence estimates are in the range of 5% to 6%1,2 and may be greater among women. Phantom odor perception has been correlated with depression3,4 and has been described in relation to migraine aura,5 radiation therapy,6 sinonasal disease, post–upper respiratory tract viral infection,7 and head trauma,8 although most evidence has been limited to case reports and small clinical studies. The biological mechanism of phantom odor perception is thought to arise from aberrant peripheral olfactory sensory neurons9 signaling perception centers in the brain, or overactive brain cells creating the perception.9,10 Reports of phantom odors have not been correlated with objective measures of olfactory loss.2,11 Phantom odor symptoms may disappear, improve, or worsen over time,12 and treatments are not reliably effective.9,13


  • Voice disorders and associated risk markers among young adults in the United States

    by Kathleen E. Bainbridge, Nelson Roy, Katalin G. Losonczy, Howard J. Hoffman, Seth M. Cohen

    Objectives/Hypothesis: To examine the prevalence of voice disorders in young adults and identify sociodemographic factors, health conditions, and behaviors associated with voice disorder prevalence.Study Design: Cross‐sectional analysis of data from the National Longitudinal Study of Adolescent to Adult Health.Methods: During home interviews, 14,794 young adults, aged 24 to 34 years, reported their health conditions and behaviors. Presence and duration of voice disorders were reported over the past 12 months. We computed overall and stratified prevalence estimates by age, gender, race/ethnicity, medical conditions, smoking, and alcohol use. Multiple logistic regression was used to identify independent risk factors for a voice disorder while accounting for the complex sample design.Results: Six percent of participants reported a voice disorder lasting at least 3 days. Females had 56% greater odds of voice disorders than males. Number of days drinking alcohol was associated with voice disorders, but number of smoking days was not. Conditions that increased the likelihood of voice disorders included hypertension (OR = 1.42 [95% confidence interval {CI}: 1.07‐1.89]), tinnitus (OR = 1.53 [95% CI: 1.06‐2.20]), and anxiety/panic disorder (OR = 1.26 [95% CI: 1.00‐1.60]). Results were independent of gender, alcohol consumption, upper respiratory symptoms, and lower respiratory conditions including asthma, bronchitis/emphysema, and gastrointestinal symptoms (diarrhea/nausea/vomiting).Conclusions: Voice disorders in young adulthood were associated with hypertension, tinnitus, and anxiety. Greater awareness of these relationships may facilitate voice evaluation among people who seek healthcare for these chronic conditions.Level of Evidence: 2b Laryngoscope, 127:2093–2099, 2017


  • Open Access

    Risk factors for hearing impairment among adults with diabetes: The Hispanic Community Health Study/Study of Latinos (HCHS/SOL)

    by Kathleen E. Bainbridge, Catherine C. Cowie, Franklyn Gonzalez, Howard J. Hoffman, Elizabeth Dinces, Jeremiah Stamler, Karen J. Cruickshanks


  • Hearing Aid Use Among Older U.S. Adults

    by Kathleen E. Bainbridge, Virginia Ramachandran

    Objectives: The authors estimated the proportion of older adults in the United States who report hearing aid use among those likely to benefit. To more fully understand what factors underlie the low proportion of hearing aid use, the authors examined a variety of socio-demographic correlates as well as measures of health care access and insurance status in relation to hearing aid use among potential hearing aid candidates. Design: The study makes use of cross-sectional data collected during 2005–2006 and 2009–2010 as part of the National Health and Nutrition Examination Survey. The 1636 adults aged 70 years and older were selected by using a complex sampling design and comprise a nationally representative sample. In addition to self-reported hearing aid use, data on pure-tone thresholds, perceived hearing ability, place for routine health care, time since last hearing test, type of insurance coverage, and socio-demographic characteristics including age, sex, race/ethnicity, family size, and income-to-poverty ratio were collected. The analytical sample consisted of 601 adults who had a better-ear pure-tone average of ≥35 dB HL at 500, 1000, and 2000 Hz or who reported moderate or worse hearing ability. Results: One third of the potential hearing aid candidates reported current use of hearing aids. The authors observed a 28 to 66% greater prevalence of hearing aid use among older adults in the upper four fifths of the income-to-poverty distribution compared with those in the bottom one fifth. Compared with people who had their hearing tested 5 to 9 years ago, those with more recent hearing tests were more than two to three times as likely to be a current hearing aid user. No differences were observed by age after adjusting for pure-tone average and no differences were observed by sex after adjusting for perceived hearing ability. No differences were observed by place of routine health care or by type of insurance coverage. Conclusions: Use of hearing aids is low among older adults who might benefit. Identifying and surmounting barriers to hearing aid use, especially among low-income adults, remains an important objective for hearing health care in the United States.


  • Top Cited Papers

    Hearing Loss in an Aging American Population: Extent, Impact, and Management

    by Kathleen E. Bainbridge, Margaret I. Wallhagen

    Despite contributing substantially to disability in the United States, age-related hearing loss is an underappreciated public health concern. Loss of hearing sensitivity has been documented in two-thirds of adults aged 70 years and older and has been associated with communication difficulties, lower health-related quality of life, and decreased physical and cognitive function. Management strategies for age-related hearing loss are costly, yet the indirect costs due to lost productivity among people with communication difficulties are also substantial and likely to grow. Hearing aids can improve health-related quality of life, but the majority of people with documented hearing loss do not report using them. Uncovering effective means to improve the utilization of hearing health care services is essential for meeting the hearing health care demands of our aging population. The importance of hearing for general well-being warrants an effort to enhance awareness among the general population of the indications of hearing loss and options for assistance.


  • Open Access

    Risk Factors for Hearing Impairment Among U.S. Adults With Diabetes

    by Kathleen E. Bainbridge, Howard J. Hoffman, Catherine C. Cowie

    OBJECTIVE: The objective of this study was to examine the risk factors of low/mid-frequency and high-frequency hearing impairment among a nationally representative sample of diabetic adults. RESEARCH DESIGN AND METHODS: Data came from 536 participants, aged 20–69 years, with diagnosed or undiagnosed diabetes who completed audiometric testing during 1999–2004 in the National Health and Nutrition Examination Survey (NHANES). We defined hearing impairment as the pure-tone average >25 dB hearing level of pure-tone thresholds at low/mid-frequencies (500; 1,000; and 2,000 Hz) and high frequencies (3,000; 4,000; 6,000; and 8,000 Hz) and identified independent risk factors using logistic regression. RESULTS: Controlling for age, race/ethnicity, and marital status, odds ratios for associations with low/mid-frequency hearing impairment were 2.20 (95% CI 1.28–3.79) for HDL <40 mg/dL and 3.55 (1.57–8.03) for poor health. Controlling for age, race/ethnicity, sex, and income-to-poverty ratio, odds ratios for associations with high-frequency hearing impairment were 4.39 (1.26–15.26) for history of coronary heart disease and 4.42 (1.26–15.45) for peripheral neuropathy. CONCLUSIONS: Low HDL, coronary heart disease, peripheral neuropathy, and having poor health are potentially preventable correlates of hearing impairment for people with diabetes. Glycemic control, years since diagnosis, and type of glycemic medication were not associated with hearing impairment.